Corcept shares drop 50% after FDA rejects drug application

March 10, 2026 10:20 PM

Corcept Therapeutics Incorporated (NASDAQ: CORT) faces a securities class action lawsuit following a 50% stock decline after the Food and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found